Recent news on Metformin Hydrochloride

Depomed to Present at the Bank of America 2007 Healthcare Conference  -  May 22, 2007
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United

Avandia: Getting the Facts  -  May 22, 2007
FOX News...s Janumet is an oral medicine combining sitagliptin phosphate with metformin hydrochloride. It is designed for patients who need more than one oral

Mylan Announces Final FDA Approval for Glipizide and Metformin ...  -  Apr 16, 2007
Drug Newswire (press release),Glipizide and Metformin Hydrochloride Tablets are the generic version of Bristol Myers Squibb's Metaglip(TM) Tablets. Glipizide and Metformin Hydrochloride

Mylan Unveils FDA Approval For Glipizide And Metformin ...  -  Apr 13, 2007
Trading Markets,The Canonsburg, Pennsylvania-based company noted that the Glipizide and Metformin Hydrochloride Tablets are the generic version of Bristol Myers Squibb's

Mylan Laboratories (MYL) Receives Final FDA Approval for Glipizide ...  -  Apr 13, 2007
StreetInsider.com (subscription),Glipizide and Metformin Hydrochloride Tablets are the generic version of Bristol Myers Squibb's (NYSE: BMY) Metaglip Tablets.

Mylan Pharma. Gets Final FDA Approval For Glipizide And Metformin ...  -  Apr 13, 2007
Trading Markets,The company noted that the products that are planning to be shipped immediately, Glipizide and Metformin Hydrochloride Tablets are the generic version of

Depomed to Announce First Quarter 2007 Financial Results on ...  -  Apr 25, 2007
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United

Depomed Completes $20 Million Registered Direct Offering  -  Apr 23, 2007
PharmaLive.com (press release),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

Depomed Files Prior Approval Supplement for 1000 mg Strength ...  -  Apr 2, 2007
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended release tablets) is indicated alone or in combination with sulfonylurea or insulin as an adjunct to diet and

Market Report -- In Play (MYL)  -  Apr 13, 2007
MSN MoneyMylan Labs announces final FDA approval for glipizide and metformin hydrochloride tablets Co announces that Mylan Pharmaceuticals has received final

Mylan gets FDA OK for generic Metaglip  -  Apr 13, 2007
ReutersMylan got marketing approval from the US Food and Drug Administration for Glipizide and Metformin Hydrochloride Tablets in 2.5 mg/250 mg, 2.5 mg/500 mg and

Mylan OK'd on generic Metaglip  -  Apr 13, 2007
United Press InternationalThe US Food and Drug Administration approved Mylan's glipizide and metformin hydrochloride tablets in 2.5-mg/250-mg, 2.5-mg/500-mg and 5-mg/500-mg strengths

Depomed to Present at the CIBC World Markets Annual Biotechnology ...  -  Apr 4, 2007
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United

FDA Approves JANUMET™ For Type 2 Diabetes, Offering Powerful ...  -  Apr 2, 2007
Medical News Today (press release),The reported incidence of lactic acidosis in patients receiving metformin hydrochloride is very low (approximately 0.03 cases/1000 patientyears,

Depomed Appoints David Zenoff to Board of Directors  -  Mar 23, 2007
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is being marketed in the United

Depomed Reports 2006 Year End Financial Results  -  Mar 14, 2007
Genetic Engineering News (press release),In addition, $526000 was in product sales of Glumetza(TM) (metformin hydrochloride extended release tablets) through King Pharmaceuticals and $109000 was

Depomed to Announce Fourth Quarter and Year End 2006 Financial ...  -  Feb 28, 2007
PharmaLive.com (press release),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

Depomed and Biovail Sign License Agreement for AcuForm(TM) Drug ...  -  Feb 12, 2007
CNW Telbec (Communiqués de presse),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

Depomed Announces Sweeping Interim Victory in Litigation against Ivax  -  18 Jan 2007
PharmaLive.com (press release),6340475 and 6635280 by Ivax's extended release metformin hydrochloride tablets. The patents are held by Depomed and relate to the company's AcuForm(TM) drug

Loyalty program for diabetes patients  -  18 Jan 2007
Colloquy.com (subscription),...launch of a program that providing support for diabetes patients receiving treatment with Glumetza (metformin hydrochloride extended-release tablets),

Depomed Receives $10 Million License Fee from Esprit and Withdraws ...  -  Jan 12, 2007
PharmaLive.com (press release),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

Depomed Announces Sweeping Interim Victory in Litigation against Ivax  -  Dec 21, 2006
PharmaLive.com (press release),6340475 and 6635280 by Ivax's extended release metformin hydrochloride tablets. The patents are held by Depomed and relate to the company's AcuForm(TM) drug

Depomed Receives $10 Million License Fee from Esprit and Withdraws ...  -  Dec 22, 2006
PharmaLive.com (press release),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

TODAY ON PHARMALIVE.COM  -  Dec 8, 2006
PharmaLive.com (press release),...decision to withdraw its application for a centralised marketing authorisation for the medicinal product Synordia (fenofibrate/metformin hydrochloride).

Solvay's Fournier withdraws marketing application for Synordia - EMEA  -  Dec 8, 2006
Forbes,...owned by Belgian chemicals group Solvay SA, was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride).

Loyalty program for diabetes patients  -  Dec 21, 2006
Colloquy.com (subscription),...launch of a program that providing support for diabetes patients receiving treatment with Glumetza (metformin hydrochloride extended-release tablets),

Brussels shares close higher as Suez, KBC and UCB rise UPDATE  -  Dec 8, 2006
Forbes,...unit Fournier Laboratories Ireland Ltd was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride).

Depomed Reports Third Quarter 2006 Financial Results  09 Nov 2006
In addition, once daily Glumetza TM (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... -Business Wire (press release), Depomed to Present at the UBS Global Life Sciences Conference  Sep 20, 2006
In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is ... -Business Wire

New Once-Daily Oral Diabetes Treatment Glumetza(TM) Now Available  Sep 6, 2006
...(NASDAQ: DEPO) today announced the commercial availability of Glumetza(TM) (metformin hydrochloride extended release tablets) in the United States. ... -Genetic Engineering News

FDA's thumbs up to PFI reverberates through outsourcing industry  Aug 30, 2006
...the first drug master file (DMF) approval of its kind, the US Food and Drug Administration (FDA) has approved the sale of metformin hydrochloride tablets which ... -DrugResearcher.com

Patheon breaks into drug delivery  Aug 29, 2006
...for the treatment of uncomplicated urinary tract infections, and Glumetza, a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the ... -In-PharmaTechnologist.com

Depomed Announces Equity Financing Commitment of Up to $30 Million  -  12 Dec 2006
Business Wire (press release),In addition, once daily Glumetza TM (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

TODAY ON PHARMALIVE.COM  -  Dec 8, 2006
PharmaLive.com (press release),...decision to withdraw its application for a centralised marketing authorisation for the medicinal product Synordia (fenofibrate/metformin hydrochloride).

Solvay's Fournier withdraws marketing application for Synordia - EMEA  -  Dec 8, 2006
Forbes,...owned by Belgian chemicals group Solvay SA, was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride).

New Patient Support Program Offers Savings on Glumetza Therapy for ...  -  Nov 21, 2006
PharmaLive.com (press release),Glumetza(TM) (metformin hydrochloride extended-release tablets) is indicated alone or in combination with sulfonylurea or insulin as an adjunct to diet and

Diabetes :: Contributing To The Fight Against Diabetes Is Only A ...  -  Nov 16, 2006
SpiritIndia,King Pharmaceuticals and Depomed market Glumetza™ (metformin hydrochloride extended release tablets), a new once-daily extended-release metformin

Depomed Comments on Today's Trading Activity  -  Dec 5, 2006
PharmaLive.com (press release),In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with type 2 diabetes and is

Brussels shares close higher as Suez, KBC and UCB rise UPDATE  -  Dec 8, 2006
Forbes,...unit Fournier Laboratories Ireland Ltd was withdrawing its marketing authorisation application for Synordia (fenofibrate/metformin hydrochloride).

Buy Granules India with target of Rs 150: Karvy  -  Nov 14, 2006
Moneycontrol.com,Along with a US-based Amneal Pharmaceuticals LLC, it has received an approval for Metformin Hydrochloride tablets. This is the first time that the USFDA has

Diabetes :: Patient Support Program Offers Savings on Glumetza ...  -  Nov 23, 2006
SpiritIndia,...that will provide support for patients with diabetes who are receiving treatment with Glumetza (metformin hydrochloride extended-release tablets),

Patheon breaks into drug delivery  29 Aug 2006
...for the treatment of uncomplicated urinary tract infections, and Glumetza, a once-daily, extended-release formulation of metformin hydrochloride (HCl) for the ... -In-PharmaTechnologist.com

TODAY ON PHARMALIVE.COM  Aug 23, 2006
...(NYSE:KG) announced today that as they prepare for the launch of Glumetza(TM) (metformin hydrochloride extended-release tablets), a new consensus statement was ... -PharmaLive.com

Merck Provides Preliminary Analyses of the Completed MEDAL Program ...  Aug 24, 2006
...(NYSE:KG) announced recently that as they prepare for the launch of Glumetza(TM) (metformin hydrochloride extended-release tablets), a new consensus statement ... -Financial News USA

Depomed Reports Second Quarter 2006 Financial Results; Revenues ...  Aug 7, 2006
In addition, once daily Glumetza(TM) (metformin hydrochloride extended release tablets) has been approved for use in adults with Type II diabetes and is ... -Business Wire

Granules India gets USFDA nod for intermediates  Aug 1, 2006
LLC have announced that they have received approval for the abbreviated new drug application (ANDA) of anti-diabetic drug Metformin Hydrochloride tablets of ... -Moneycontrol.com

Granules India receives 1st FDA approval for ANDA with PFI  Aug 2, 2006
...and Amneal Pharmaceuticals LLC (United States) are pleased to announce the approval of the ANDA of Metformin Hydrochloride tablets of 500 mg, 850 mg and 1000 mg ... -Moneycontrol.com

King Pharmaceuticals Reports Second-Quarter 2006 Financial Results  Aug 9, 2006
...reinvigorate demand for Altace(R). Additionally, this opportunity, coupled with the recent addition of Glumetza(TM) (metformin hydrochloride extended-release ... -Business Wire

Granules India Receives First FDA Approval For An ANDA With A PFI  Aug 1, 2006
Granules India informed that the company and Amneal Pharmaceuticals LLC, US, announced the maiden approval of the ANDA of Metformin Hydrochloride tablets of ... -Trading Markets

Granules India receives first FDA approval for an ANDA with a PFI  Aug 1, 2006
Granules India (Q, N,C,F)* and Amneal Pharmaceuticals LLC (United States) have announced the approval of the ANDA of Metformin Hydrochloride tablets of 500 mg ... -Myiris.com

Depomed Unveils Data at the Endocrine Society Meeting Showing ...  Jun 29, 2006
In addition, regulatory applications for once daily Glumetza(TM) (metformin hydrochloride extended-release tablets)for the treatment of Type 2 diabetes have ... -Genetic Engineering News

Avandamet Approved for New Indication  Jul 12, 2006
The FDA has approved GlaxoSmithKline’s Avandamet (rosiglitazone maleate/metformin hydrochloride) tablets for use in the initial treatment of type 2 diabetes ... -Facts and Comparisons

King Pharmaceuticals and Depomed Announce Agreement to Co-Promote ...  Jun 28, 2006
DEPO) announced today that they have entered into a co-exclusive agreement to commercialize Depomed's Glumetza(TM) (metformin hydrochloride extended-release ... -Genetic Engineering News



FDA finds dozens new deficiencies at Andrx  Apr 25, 2006
Metformin Hydrochloride Extended Release is generic Glucophage XR; Diltia XT is generic Dilacor XR; and Ketoprofen ER is generic Oruvail. ... - Sun-Sentinel.com





SNDA for a Fast-acting Postprandial Hypoglicemic Agent FASTIC ...  Jan 27, 2006
...agents that improve insulin resistance by the main action mechanism of hepatic glucose production inhibition of which metformin hydrochloride and buformin ... - PharmaLive.com

Stocks Under $10 Weekly Summary  Jan 20, 2006
...suit filed last week against Ivax (IVX:Amex), DepoMed is alleging that Ivax's diabetes treatment, extended release metformin hydrochloride, infringes DepoMed's ... - TheStreet.com (subscription)

Preserving Competition, FTC Requires Divestitures Before Allowing ...  Jan 23, 2006
...from Teva, to be divested to Par; 12) tramadol/acetaminophen tablets from Teva, to be divested to Barr; 13) glipizide and metformin hydrochloride tablets from ... - PharmaLive.com

Do the math: Same drugs, lower price  Jan 15, 2006
For example, Metformin hydrochloride, a diabetes drug, cost $18 at Johnson compared with $88.19 at Walgreens and $85.59 at CVS at the same quantity and ... - Boston Globe

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional